Harmony Biosciences Holdings Inc (NAS:HRMY)
$ 29.95 0.6 (2.04%) Market Cap: 1.70 Bil Enterprise Value: 1.52 Bil PE Ratio: 12.97 PB Ratio: 3.30 GF Score: 63/100

Harmony Biosciences Holdings Inc at JPMorgan Healthcare Conference Transcript

Jan 11, 2024 / 01:15AM GMT
Release Date Price: $31.37 (-1.57%)
Unidentified Paricipant

Welcome, everyone. I'm [Sanjeevitha] with JPMorgan Healthcare, and we're pleased to have with us Dr.Jeffrey M. Dayno, President and CEO of Harmony Biosciences. For logistics purposes please reserve any questions you may have to the end of the presentation. With that, I will let Jeffrey take over.

Jeffrey Dayno Harmony Biosciences Holdings
Inc. - President and CEO

Thank you, Sanjeevitha. Good afternoon, everyone, and thank you for attending our session late on a Wednesday afternoon and appreciate your interest in Harmony and on behalf of the Harmony team, our thanks to JPMorgan for the invitation to present again of this year. Our forward-looking statements, please refer to our SEC filings for the latest information.

So for those of you newer to the story, excited to share with you today Harmony Biosciences, and who we are. So we are now 260 members strong on sort of industry veterans and we specialize in developing and commercializing innovative treatments for patients living with rare neurological diseases and in other chronic

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot